Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 10/2014

01.10.2014 | Genetics (V Bonifati, Section Editor)

The Genetics of Primary Familial Brain Calcifications

verfasst von: Ana Westenberger, Christine Klein

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Bilateral accumulation of calcium in the brain, most commonly in the basal ganglia, but also in the cerebellum, thalamus, and brainstem can be inherited in an autosomal dominant fashion and is then referred to as primary familial brain calcifications (PFBC). Clinical manifestations include a spectrum of movement disorders and neuropsychiatric abnormalities. In the past 2 years, 3 genes have been identified to cause PFBC, (ie, SLC20A2, PDGFRB, and PDGFB). SCL20A2 encodes the Type III sodium-dependent inorganic phosphate (Pi) transporter 2 (PiT2) and, when mutated, uptake of Pi is severely impaired likely causing buildup of calcium phosphate. The second identified cause of PFBC is mutations in PDGFRB, which codes for platelet-derived growth factor receptor β (PDGF-Rβ). Interestingly, the third PFBC gene is PDGFB that encodes the ligand of PDGF-Rβ, which is secreted during angiogenesis to recruit pericytes, thereby implying impairment of the blood-brain barrier as a disease mechanism of PFBC.
Literatur
1.
Zurück zum Zitat Baba Y, Broderick DF, Uitti RJ, Hutton ML, Wszolek ZK. Heredofamilial brain calcinosis syndrome. Mayo Clin Proc. 2005;80(5):641–51.PubMedCrossRef Baba Y, Broderick DF, Uitti RJ, Hutton ML, Wszolek ZK. Heredofamilial brain calcinosis syndrome. Mayo Clin Proc. 2005;80(5):641–51.PubMedCrossRef
2.•
Zurück zum Zitat Sobrido MJ, Coppola G, Oliveira J, Hopfer S, Geschwind DH. Primary Familial Brain Calcification. GeneReviews (Internet). Seattle: University of Washington; 2004. p. 1993–2014. This publication is of importance given that it is currently the most comprehensive review of all aspects of PFBC. Sobrido MJ, Coppola G, Oliveira J, Hopfer S, Geschwind DH. Primary Familial Brain Calcification. GeneReviews (Internet). Seattle: University of Washington; 2004. p. 1993–2014. This publication is of importance given that it is currently the most comprehensive review of all aspects of PFBC.
3.
Zurück zum Zitat Forstl H, Krumm B, Eden S, Kohlmeyer K. Neurological disorders in 166 patients with basal ganglia calcification: a statistical evaluation. J Neurol. 1992;239(1):36–8.PubMedCrossRef Forstl H, Krumm B, Eden S, Kohlmeyer K. Neurological disorders in 166 patients with basal ganglia calcification: a statistical evaluation. J Neurol. 1992;239(1):36–8.PubMedCrossRef
4.
Zurück zum Zitat Yamada M, Asano T, Okamoto K, Hayashi Y, Kanematsu M, Hoshi H, et al. High frequency of calcification in basal ganglia on brain computed tomography images in Japanese older adults. Geriatr Gerontol Int. 2013;13(3):706–10.PubMedCrossRef Yamada M, Asano T, Okamoto K, Hayashi Y, Kanematsu M, Hoshi H, et al. High frequency of calcification in basal ganglia on brain computed tomography images in Japanese older adults. Geriatr Gerontol Int. 2013;13(3):706–10.PubMedCrossRef
5.
Zurück zum Zitat Fahr T. Idiopathische Verkalkung der Hirngefässe. Zbl Allg Pathol Pathol Anat. 1930;50:129–30. Fahr T. Idiopathische Verkalkung der Hirngefässe. Zbl Allg Pathol Pathol Anat. 1930;50:129–30.
6.
7.
Zurück zum Zitat Delacour A. Ossification des capillaires du cerveau. Ann Med Psychol. 1850;2:458–61. Delacour A. Ossification des capillaires du cerveau. Ann Med Psychol. 1850;2:458–61.
8.
Zurück zum Zitat Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet. 1999;65(3):764–72.PubMedCrossRefPubMedCentral Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet. 1999;65(3):764–72.PubMedCrossRefPubMedCentral
9.
Zurück zum Zitat Volpato CB, De Grandi A, Buffone E, Facheris M, Gebert U, Schifferle G, et al. 2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family. J Mol Neurosci. 2009;39(3):346–53.PubMedCrossRef Volpato CB, De Grandi A, Buffone E, Facheris M, Gebert U, Schifferle G, et al. 2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family. J Mol Neurosci. 2009;39(3):346–53.PubMedCrossRef
10.
Zurück zum Zitat Dai X, Gao Y, Xu Z, Cui X, Liu J, Li Y, et al. Identification of a novel genetic locus on chromosome 8p21.1-q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(7):1305–10.PubMedCrossRef Dai X, Gao Y, Xu Z, Cui X, Liu J, Li Y, et al. Identification of a novel genetic locus on chromosome 8p21.1-q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(7):1305–10.PubMedCrossRef
11.••
Zurück zum Zitat Nicolas G, Pottier C, Maltete D, Coutant S, Rovelet-Lecrux A, Legallic S, et al. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology. 2013;80(2):181–7. This publication is of major importance as it reports for the first time mutations in PDGFRB as a cause of PFBC.PubMedCrossRef Nicolas G, Pottier C, Maltete D, Coutant S, Rovelet-Lecrux A, Legallic S, et al. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology. 2013;80(2):181–7. This publication is of major importance as it reports for the first time mutations in PDGFRB as a cause of PFBC.PubMedCrossRef
12.••
Zurück zum Zitat Keller A, Westenberger A, Sobrido MJ, Garcia-Murias M, Domingo A, Sears RL, et al. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet. 2013;45(9):1077–82. This publication is of major importance given that it reports for the first time mutations in PDGFB as a cause of PFBC.PubMedCrossRef Keller A, Westenberger A, Sobrido MJ, Garcia-Murias M, Domingo A, Sears RL, et al. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet. 2013;45(9):1077–82. This publication is of major importance given that it reports for the first time mutations in PDGFB as a cause of PFBC.PubMedCrossRef
13.
Zurück zum Zitat Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. Neurology. 2012;78(13):1016–24.PubMedCrossRefPubMedCentral Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. Neurology. 2012;78(13):1016–24.PubMedCrossRefPubMedCentral
14.•
Zurück zum Zitat Hsu SC, Sears RL, Lemos RR, Quintans B, Huang A, Spiteri E, et al. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics. 2013;14(1):11–22. This publication is of importance since it is the most extensive screening study of the SLC20A2 gene in patients with a positive family history published to date. It also reports that mutations in SLC20A2 are the cause of PFBC in the family originaly thought to be linked to the IBGC1 locus.PubMedCrossRefPubMedCentral Hsu SC, Sears RL, Lemos RR, Quintans B, Huang A, Spiteri E, et al. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics. 2013;14(1):11–22. This publication is of importance since it is the most extensive screening study of the SLC20A2 gene in patients with a positive family history published to date. It also reports that mutations in SLC20A2 are the cause of PFBC in the family originaly thought to be linked to the IBGC1 locus.PubMedCrossRefPubMedCentral
15.••
Zurück zum Zitat Wang C, Li Y, Shi L, Ren J, Patti M, Wang T, et al. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet. 2012;44(3):254–6. This publication is of major importance given that it reports for the first time mutations in SLC20A2 as a cause of PFBC.PubMedCrossRef Wang C, Li Y, Shi L, Ren J, Patti M, Wang T, et al. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet. 2012;44(3):254–6. This publication is of major importance given that it reports for the first time mutations in SLC20A2 as a cause of PFBC.PubMedCrossRef
16.•
Zurück zum Zitat Yamada M, Tanaka M, Takagi M, Kobayashi S, Taguchi Y, Takashima S, et al. Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan. Neurology. 2014;82(8):705–12. This publication is of importance because it is the most extensive screening study of the SLC20A2 gene in the Japanese population of familial and sporadic PFBC cases published to date.PubMedCrossRef Yamada M, Tanaka M, Takagi M, Kobayashi S, Taguchi Y, Takashima S, et al. Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan. Neurology. 2014;82(8):705–12. This publication is of importance because it is the most extensive screening study of the SLC20A2 gene in the Japanese population of familial and sporadic PFBC cases published to date.PubMedCrossRef
17.
Zurück zum Zitat Bottger P, Pedersen L. Mapping of the minimal inorganic phosphate transporting unit of human PiT2 suggests a structure universal to PiT-related proteins from all kingdoms of life. BMC Biochem. 2011;12:21.PubMedCrossRefPubMedCentral Bottger P, Pedersen L. Mapping of the minimal inorganic phosphate transporting unit of human PiT2 suggests a structure universal to PiT-related proteins from all kingdoms of life. BMC Biochem. 2011;12:21.PubMedCrossRefPubMedCentral
18.•
Zurück zum Zitat Baker M, Strongosky AJ, Sanchez-Contreras MY, Yang S, Ferguson W, Calne DB, et al. SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia. Neurogenetics. 2014;15(1):23–30. This publication is of importance given that it reports the first deletion that involves the entire SLC20A2 gene, as well as the entire THAP1 gene.PubMedCrossRef Baker M, Strongosky AJ, Sanchez-Contreras MY, Yang S, Ferguson W, Calne DB, et al. SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia. Neurogenetics. 2014;15(1):23–30. This publication is of importance given that it reports the first deletion that involves the entire SLC20A2 gene, as well as the entire THAP1 gene.PubMedCrossRef
19.
Zurück zum Zitat Jensen N, Schroder HD, Hejbol EK, Fuchtbauer EM, de Oliveira JR, Pedersen L. Loss of function of Slc20a2 associated with familial idiopathic Basal Ganglia calcification in humans causes brain calcifications in mice. J Mol Neurosci. 2013;51(3):994–9.PubMedCrossRefPubMedCentral Jensen N, Schroder HD, Hejbol EK, Fuchtbauer EM, de Oliveira JR, Pedersen L. Loss of function of Slc20a2 associated with familial idiopathic Basal Ganglia calcification in humans causes brain calcifications in mice. J Mol Neurosci. 2013;51(3):994–9.PubMedCrossRefPubMedCentral
20.
Zurück zum Zitat Kobayashi S, Yamadori I, Miki H, Ohmori M. Idiopathic nonarteriosclerotic cerebral calcification (Fahr's disease): an electron microscopic study. Acta Neuropathol. 1987;73(1):62–6.PubMedCrossRef Kobayashi S, Yamadori I, Miki H, Ohmori M. Idiopathic nonarteriosclerotic cerebral calcification (Fahr's disease): an electron microscopic study. Acta Neuropathol. 1987;73(1):62–6.PubMedCrossRef
21.•
Zurück zum Zitat Nicolas G, Pottier C, Charbonnier C, Guyant-Marechal L, Le Ber I, Pariente J, et al. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain. 2013;136(Pt 11):3395–407. This publication is of importance given that it provides the first comprehensive overview of clinical features of patients affected by definite (caused by mutations in SLC20A2 and PDGFRB) and probable PFBC. PubMedCrossRef Nicolas G, Pottier C, Charbonnier C, Guyant-Marechal L, Le Ber I, Pariente J, et al. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain. 2013;136(Pt 11):3395–407. This publication is of importance given that it provides the first comprehensive overview of clinical features of patients affected by definite (caused by mutations in SLC20A2 and PDGFRB) and probable PFBC. PubMedCrossRef
22.•
Zurück zum Zitat Sanchez-Contreras M, Baker MC, Finch NA, Nicholson A, Wojtas A, Wszolek ZK, et al. Genetic Screening and Functional Characterization of PDGFRB Mutations Associated With Basal Ganglia Calcification of Unknown Etiology. Hum Mutat. 2014. doi:10.1002/humu.22582. This publication is of importance as it reports the first study of pathogenic mechanisms of the mutations in the PDGF-Rβ gene causing PFBC.PubMed Sanchez-Contreras M, Baker MC, Finch NA, Nicholson A, Wojtas A, Wszolek ZK, et al. Genetic Screening and Functional Characterization of PDGFRB Mutations Associated With Basal Ganglia Calcification of Unknown Etiology. Hum Mutat. 2014. doi:10.​1002/​humu.​22582. This publication is of importance as it reports the first study of pathogenic mechanisms of the mutations in the PDGF-Rβ gene causing PFBC.PubMed
23.
24.
Zurück zum Zitat Martignetti JA, Tian L, Li D, Ramirez MC, Camacho-Vanegas O, Camacho SC, et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet. 2013;92(6):1001–7.PubMedCrossRefPubMedCentral Martignetti JA, Tian L, Li D, Ramirez MC, Camacho-Vanegas O, Camacho SC, et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet. 2013;92(6):1001–7.PubMedCrossRefPubMedCentral
25.
Zurück zum Zitat Cheung YH, Gayden T, Campeau PM, LeDuc CA, Russo D, Nguyen VH, et al. A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Am J Hum Genet. 2013;92(6):996–1000.PubMedCrossRefPubMedCentral Cheung YH, Gayden T, Campeau PM, LeDuc CA, Russo D, Nguyen VH, et al. A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Am J Hum Genet. 2013;92(6):996–1000.PubMedCrossRefPubMedCentral
26.
Zurück zum Zitat Nicolas G, Rovelet-Lecrux A, Pottier C, Martinaud O, Wallon D, Vernier L, et al. PDGFB partial deletion: a new, rare mechanism causing brain calcification with leukoencephalopathy. J Mol Neurosci. 2014;53(2):171–5.PubMedCrossRef Nicolas G, Rovelet-Lecrux A, Pottier C, Martinaud O, Wallon D, Vernier L, et al. PDGFB partial deletion: a new, rare mechanism causing brain calcification with leukoencephalopathy. J Mol Neurosci. 2014;53(2):171–5.PubMedCrossRef
27.
Zurück zum Zitat Nicolas G, Jacquin A, Thauvin-Robinet C, Rovelet-Lecrux A, Rouaud O, Pottier C, et al. A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia. Eur J Hum Genet. 2014. doi:10.1038/ejhg.2014.9 Nicolas G, Jacquin A, Thauvin-Robinet C, Rovelet-Lecrux A, Rouaud O, Pottier C, et al. A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia. Eur J Hum Genet. 2014. doi:10.​1038/​ejhg.​2014.​9
28.
Zurück zum Zitat Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193–215.PubMedCrossRef Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193–215.PubMedCrossRef
29.
Zurück zum Zitat Gaengel K, Genove G, Armulik A, Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29(5):630–8.PubMedCrossRef Gaengel K, Genove G, Armulik A, Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29(5):630–8.PubMedCrossRef
30.
Zurück zum Zitat Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468(7323):557–61.PubMedCrossRef Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468(7323):557–61.PubMedCrossRef
31.
Zurück zum Zitat Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord. 2001;16(2):258–64.PubMedCrossRef Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord. 2001;16(2):258–64.PubMedCrossRef
32.
Zurück zum Zitat Larsen TA, Dunn HG, Jan JE, Calne DB. Dystonia and calcification of the basal ganglia. Neurology. 1985;35(4):533–7.PubMedCrossRef Larsen TA, Dunn HG, Jan JE, Calne DB. Dystonia and calcification of the basal ganglia. Neurology. 1985;35(4):533–7.PubMedCrossRef
33.
Zurück zum Zitat Zhang Y, Guo X, Wu A. Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification. PLoS One. 2013;8(2):e57060.PubMedCrossRefPubMedCentral Zhang Y, Guo X, Wu A. Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification. PLoS One. 2013;8(2):e57060.PubMedCrossRefPubMedCentral
34.
Zurück zum Zitat Brodaty H, Mitchell P, Luscombe G, Kwok JJ, Badenhop RF, McKenzie R, et al. Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum Genet. 2002;110(1):8–14.PubMedCrossRef Brodaty H, Mitchell P, Luscombe G, Kwok JJ, Badenhop RF, McKenzie R, et al. Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum Genet. 2002;110(1):8–14.PubMedCrossRef
35.
Zurück zum Zitat Oliveira JR, Spiteri E, Sobrido MJ, Hopfer S, Klepper J, Voit T, et al. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology. 2004;63(11):2165–7.PubMedCrossRef Oliveira JR, Spiteri E, Sobrido MJ, Hopfer S, Klepper J, Voit T, et al. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology. 2004;63(11):2165–7.PubMedCrossRef
36.
Zurück zum Zitat Chen WJ, Yao XP, Zhang QJ, Ni W, He J, Li HF, et al. Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification. Gene. 2013;529(1):159–62.PubMedCrossRef Chen WJ, Yao XP, Zhang QJ, Ni W, He J, Li HF, et al. Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification. Gene. 2013;529(1):159–62.PubMedCrossRef
37.
Zurück zum Zitat Kasuga K, Konno T, Saito K, Ishihara A, Nishizawa M, Ikeuchi T. A Japanese family with idiopathic basal ganglia calcification with novel SLC20A2 mutation presenting with late-onset hallucination and delusion. J Neurol. 2014;261(1):242–4.PubMedCrossRef Kasuga K, Konno T, Saito K, Ishihara A, Nishizawa M, Ikeuchi T. A Japanese family with idiopathic basal ganglia calcification with novel SLC20A2 mutation presenting with late-onset hallucination and delusion. J Neurol. 2014;261(1):242–4.PubMedCrossRef
38.
Zurück zum Zitat Zhu M, Zhu X, Wan H, Hong D. Familial IBGC caused by SLC20A2 mutation presenting as paroxysmal kinesigenic dyskinesia. Parkinsonism Relat Disord. 2014;20(3):353–4.PubMedCrossRef Zhu M, Zhu X, Wan H, Hong D. Familial IBGC caused by SLC20A2 mutation presenting as paroxysmal kinesigenic dyskinesia. Parkinsonism Relat Disord. 2014;20(3):353–4.PubMedCrossRef
39.
Zurück zum Zitat Lemos RR, Oliveira MF, Oliveira JR. Reporting a new mutation at the SLC20A2 gene in familial idiopathic basal ganglia calcification. Eur J Neurol. 2013;20(3):e43–4.PubMedCrossRef Lemos RR, Oliveira MF, Oliveira JR. Reporting a new mutation at the SLC20A2 gene in familial idiopathic basal ganglia calcification. Eur J Neurol. 2013;20(3):e43–4.PubMedCrossRef
40.
Zurück zum Zitat Schottlaender L. Interesting clinical features associated with mutations in the SLC20A2 gene. Eur J Neurol. 2013;19:40. Schottlaender L. Interesting clinical features associated with mutations in the SLC20A2 gene. Eur J Neurol. 2013;19:40.
Metadaten
Titel
The Genetics of Primary Familial Brain Calcifications
verfasst von
Ana Westenberger
Christine Klein
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 10/2014
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-014-0490-4

Weitere Artikel der Ausgabe 10/2014

Current Neurology and Neuroscience Reports 10/2014 Zur Ausgabe

Demyelinating Disorders (DN Bourdette and V Yadav, Section Editors)

Remyelination and Multiple Sclerosis: Therapeutic Approaches and Challenges

Neurology of Systemic Disease (J Biller, Section Editor)

Neurologic Manifestations of Gastrointestinal and Liver Diseases

Infection (ML Solbrig, Section Editor)

Endogenous Retrovirus-K and Nervous System Diseases

Demyelinating Disorders (DN Bourdette and V Yadav, Section Editors)

X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment

Demyelinating Disorders (DN Bourdette and V Yadav, Section Editors)

Gut Microbiome and Multiple Sclerosis

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.